skip to content

Cambridge Academy of Therapeutic Sciences

 
Read more at: €2m boost for gene and cell therapy info hub

€2m boost for gene and cell therapy info hub

15 April 2021

A new EU-funded project is set to provide accessible and reliable information about cell and gene-based therapies. The € 2m initiative will develop an online hub to provide accurate information on the use of cells and genetic material to treat disease, along with evidence-based information to counter misinformation...


Read more at: Researchers call for greater awareness of unintended consequences of CRISPR gene editing

Researchers call for greater awareness of unintended consequences of CRISPR gene editing

15 April 2021

CRISPR-Cas9 genome editing can lead to unintended mutations at the targeted section of DNA in early human embryos, researchers have revealed. This highlights the need for further research into the effects of CRISPR-Cas9 genome editing, especially when used to edit human DNA in laboratory research. We and others are trying...


Read more at: Cambridge leads national drug trial to prevent deaths after COVID-19 patients leave hospital

Cambridge leads national drug trial to prevent deaths after COVID-19 patients leave hospital

26 March 2021

A UK-wide study is being launched to reduce the number of people who die in the months following a stay in hospital with COVID-19. Having survived the trauma of being hospitalised with COVID-19, far too many patients find themselves back in hospital with new or long term complications Charlotte Summers The clinical trial...


Read more at: New genetic clues point to new treatments for ‘silent’ stroke

New genetic clues point to new treatments for ‘silent’ stroke

26 March 2021

Scientists have identified new genetic clues in people who have had small and often apparently ‘silent’ strokes that are difficult to treat and a major cause of vascular dementia, according to research led by the University of Cambridge and published in The Lancet Neurology . These small and often silent lacunar strokes...


Read more at: New method developed for ‘up-sizing’ mini organs used in medical research

New method developed for ‘up-sizing’ mini organs used in medical research

9 February 2021

A team of engineers and scientists has developed a method of ‘up-sizing’ organoids: miniature collections of cells which mimic the behaviour of various organs and are promising tools for the study of human biology and disease. We need to find the right conditions to help the cells in mini-organs self-organise Yan Yan Shery...


Read more at: Beating COVID-19 by screening new medicines with heart cells

Beating COVID-19 by screening new medicines with heart cells

8 February 2021

A Fellow of St Catharine’s College, Professor Anthony Davenport (1995), is a senior author of a new study that uses artificially-grown heart cells to advance the search for new therapies for patients with COVID-19. Professor Davenport explains, “The SARS-CoV-2 virus continues to mutate and three new strains are causing...


Read more at: Study highlights risk of new SARS-CoV-2 mutations emerging during chronic infection

Study highlights risk of new SARS-CoV-2 mutations emerging during chronic infection

8 February 2021

SARS-CoV-2 mutations similar to those in the B1.1.7 UK variant could arise in cases of chronic infection, where treatment over an extended period can provide the virus multiple opportunities to evolve, say scientists. Given that both vaccines and therapeutics are aimed at the spike protein, which we saw mutate in our...


Read more at: ‘Virtual biopsies’ could replace tissue biopsies in future thanks to technique developed by Cambridge scientists

‘Virtual biopsies’ could replace tissue biopsies in future thanks to technique developed by Cambridge scientists

15 January 2021

A new advanced computing technique using routine medical scans to enable doctors to take fewer, more accurate tumour biopsies, has been developed by cancer researchers at the University of Cambridge. This is an important step towards precision tissue sampling for cancer patients to help select the best treatment. In future...


Read more at: Driving force behind cellular ‘protein factories’ could have implications for neurodegenerative disease

Driving force behind cellular ‘protein factories’ could have implications for neurodegenerative disease

17 December 2020

Researchers have identified the driving force behind a cellular process linked to neurodegenerative disorders such as Parkinson’s and motor neurone disease. There is still so much to learn about this system, which is incredibly important to fundamental biomedical science Clemens Kaminski In a study published today in...


Read more at: AI could help cut waiting times for cancer by automating mark-up of patient scans prior to radiotherapy

AI could help cut waiting times for cancer by automating mark-up of patient scans prior to radiotherapy

17 December 2020

Doctors at Addenbrooke’s Hospital in Cambridge aim to drastically cut cancer waiting times by using artificial intelligence (AI) to automate lengthy radiotherapy preparations. As clinicians we want to start radiotherapy promptly to improve survival rates and reduce anxiety. Using machine learning tools can save time for...